C Diff Prevention

Find out how the medical worker shortage and traveling workforce associated with the pandemic increased healthcare-associated infection rates and negatively impacted patient safety.

Mitigating hospital-onset Clostridioides difficile: The impact of an optimized environmental hygiene program in eight hospitals

ClinicalTrials.gov Identifier: NCT03334604.

Randomized trial misses strictly defined endpoint, but researchers point to benefit

Clostridioides difficile (C. diff) is curable, but recurrence and lingering symptoms are common. Here’s what to expect after recovering from C. diff.

Allegheny Health Network Westfield (N.Y.) Memorial Hospital has introduced a germ-killing robot that helps clear the facility of dangerous bacteria and viruses.

This study represents the first multiple-site, quasi-experimental study with control hospitals and a nonequivalent dependent variable to evaluate a 4-component intervention on HO-CDI. Following ongoing improvement in cleaning thoroughness, there was a sustained 50% decrease in HO-CDI SIRs compared t …

The fertile gut of a dog or cat brims with benevolent bacteria. Various forces can ravage this delicate population, but these microorganisms can be reestablished

The rising prevalence of antibiotic resistant microbial pathogens presents an ominous health and economic challenge to modern society. The discovery and large-scale development of antibiotic drugs in previous decades was transformational, providing cheap, effective treatment for what would previousl …

After the first year of interventions at Emory Saint Joseph's Hospital, there was a 63% decrease in hospital-onset C. diff cases as compared to the two years prior.

After the first year of interventions at Emory Saint Joseph's Hospital, there was a 63% decrease in hospital-onset C. diff cases as compared to the two years prior.

Noroxycdiff overcomes all of these problems. It can kill C. diff spores after only 2 minutes of exposure when applied at a concentration of 4 ounces per gallon of water.

Pseudomembranous colitis refers to inflammation of the large intestine or colon. It is commonly caused by a bacterium called Clostridioides difficile. It can cause symptoms of diarrhea, fever, and abdominal cramps. Learn more here.

Patients taking high-risk antibiotics and a probiotic capsule had a lower risk of healthcare-associated C diff infections.

(2022). Probiotics: insights and new opportunities for Clostridioides difficile intervention. Critical Reviews in Microbiology. Ahead of Print.

It took teamwork by a wide range of professional staff and support from leadership.

(2022). Probiotics: insights and new opportunities for Clostridioides difficile intervention. Critical Reviews in Microbiology. Ahead of Print.

ISSUES with a cleaner were the among the reasons for an outbreak of superbug infection at Worcestershire Royal Hospital.

“RT @AntibioticLeeds: #cdiff spores are “hard as nails” @drjanefreeman @HCAILeeds Hypochlorite kills them, but not alcohol! ! #NEY_AMR @Davi…”

Clostridioides difficile infection (CDI) is a life-threatening disease caused by the Gram-positive, opportunistic intestinal pathogen C. difficile. Despite the availability of antimicrobial drugs to treat CDI, such as vancomycin, metronidazole, and fidaxomicin, recurrence of infection …

The proper functioning of the human organism is dependent on a number of factors. The health condition of the organism can be often enhanced through appropriate supplementation, as well as the application of certain biological agents. Probiotics, i.e., live microorganisms that exert a beneficial eff …

A new study published today in the American Journal of Infection Control (AJIC), suggests that health care facilities can significantly reduce the incidence of hospital-onset Clostridioides difficile ...

Clostridioides difficile infection: curbing a difficult menace

Infections caused by multidrug-resistant bacteria are a major public health problem. Their transmission is strongly linked to cross contamination via inert surfaces, which can serve as reservoirs for pathogenic microorganisms. To address this problem, antibacterial materials applied to high-t …

Time, staff, and budget constraints make it difficult to expand HAI mitigation programs despite the obvious and urgent need to do so.

Harvard and MIT researchers have suggested an engineered live biotherapeutic (eLBP) may protect the gut microbiome against antibiotic-induced dysbiosis.

Hospital-acquired infections (HAI) cost $9.8 billion per year, with surgical site infections alone accounting for one-third of those costs, according to research published Monday in JAMA Internal Medicine. | Hospital-acquired infections (HAI) cost $9.8 billion per year, with surgical site infections alone accounting for one-third of those costs, according to research published Monday in JAMA Internal Medicine.